Literature DB >> 25626721

Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.

Robert Christian Wolf1, Philipp Arthur Thomann, Fabio Sambataro, Nadine Donata Wolf, Nenad Vasic, G Bernhard Landwehrmeyer, Sigurd Dietrich Süßmuth, Michael Orth.   

Abstract

Evidence from animal models and neuropathological data has revealed cerebellar pathology in Huntington's disease (HD). The extent of cerebellar dysfunction in preclinical stages and in early manifest HD is unclear. In this study, using MRI we investigated cerebellar changes in preclinical (preHD) and early manifest HD individuals. High-resolution structural MRI data at 3 Tesla were obtained from two independent preHD samples (n = 20/25 participants), from two independent cohorts of healthy controls (n = 20/24 participants) and from patients with early manifest HD (n = 20 participants). Resting-state functional MRI data were acquired from 20 healthy controls and 20 HD patients. Cerebellar volume was investigated using cerebellum-optimized voxel-based analysis methods. Corticocerebellar connectivity at rest was investigated by means of seed-region correlations. In both preHD samples, between-group analyses revealed no change of cerebellar volume. In contrast, early manifest HD patients exhibited lower right cerebellar lobule VIIa volume (p < 0.05 cluster-corrected). Within the control group regions functionally coupled to right cerebellar lobule VII comprised bilateral cerebellar regions, right prefrontal and cingulate areas, whereas within manifest HD, functional coupling was found in paracentral, lingual and inferior frontal areas. Paracentral connectivity strength in patients was associated with disease burden and motor symptoms. These data suggest intact cerebellar volume in preHD. In contrast, early manifest HD patients exhibit atrophy of specific cerebellar subregions and abnormal corticocerebellar functional coupling. In early HD, the association between paracentral lobule function and clinical parameters suggests that corticocerebellar connectivity strength is related to the evolution of HD biology and the severity of HD motor signs.

Entities:  

Mesh:

Year:  2015        PMID: 25626721     DOI: 10.1007/s00415-015-7642-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  77 in total

Review 1.  Exploring the brain network: a review on resting-state fMRI functional connectivity.

Authors:  Martijn P van den Heuvel; Hilleke E Hulshoff Pol
Journal:  Eur Neuropsychopharmacol       Date:  2010-05-14       Impact factor: 4.600

2.  Neural bases of dysphoria in early Huntington's disease.

Authors:  Sergio Paradiso; Beth M Turner; Jane S Paulsen; Ricardo Jorge; Laura L Boles Ponto; Robert G Robinson
Journal:  Psychiatry Res       Date:  2008-01-15       Impact factor: 3.222

Review 3.  Biological markers of cognition in prodromal Huntington's disease: a review.

Authors:  Kathryn V Papp; Richard F Kaplan; Peter J Snyder
Journal:  Brain Cogn       Date:  2011-09-01       Impact factor: 2.310

Review 4.  Development of biomarkers for Huntington's disease.

Authors:  David W Weir; Aaron Sturrock; Blair R Leavitt
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

5.  Clinical significance of frontal cortex abnormalities in Huntington's disease.

Authors:  Robert Christian Wolf; Stefan Klöppel
Journal:  Exp Neurol       Date:  2013-04-02       Impact factor: 5.330

Review 6.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

7.  Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development.

Authors:  Yiai Tong; Thomas J Ha; Li Liu; Andrew Nishimoto; Anton Reiner; Dan Goldowitz
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

8.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

Review 9.  The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging.

Authors:  Randy L Buckner
Journal:  Neuron       Date:  2013-10-30       Impact factor: 17.173

10.  Functional compensation of motor function in pre-symptomatic Huntington's disease.

Authors:  Stefan Klöppel; Bogdan Draganski; Hartwig R Siebner; Sarah J Tabrizi; Cornelius Weiller; Richard S J Frackowiak
Journal:  Brain       Date:  2009-04-15       Impact factor: 13.501

View more
  12 in total

Review 1.  Neurodevelopmental and Psychiatric Symptoms in Patients with a Cyst Compressing the Cerebellum: an Ongoing Enigma.

Authors:  Xavier Guell; Sheeba A Anteraper; Satrajit S Ghosh; John D E Gabrieli; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

2.  Sex-specific effects of the Huntington gene on normal neurodevelopment.

Authors:  Jessica K Lee; Yue Ding; Amy L Conrad; Elena Cattaneo; Eric Epping; Kathy Mathews; Pedro Gonzalez-Alegre; Larry Cahill; Vincent Magnotta; Bradley L Schlaggar; Joel S Perlmutter; Regina E Y Kim; Jeffrey D Dawson; Peg Nopoulos
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.

Authors:  Jessica J Steventon; Rebecca C Trueman; Da Ma; Emma Yhnell; Zubeyde Bayram-Weston; Marc Modat; Jorge Cardoso; Sebastian Ourselin; Mark Lythgoe; Andrew Stewart; Anne E Rosser; Derek K Jones
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

Review 4.  Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review.

Authors:  Lorenzo Pini; Charlotte Jacquemot; Annachiara Cagnin; Francesca Meneghello; Carlo Semenza; Dante Mantini; Antonino Vallesi
Journal:  Hum Brain Mapp       Date:  2019-09-18       Impact factor: 5.038

5.  LittleBrain: A gradient-based tool for the topographical interpretation of cerebellar neuroimaging findings.

Authors:  Xavier Guell; Mathias Goncalves; Jakub R Kaczmarzyk; John D E Gabrieli; Jeremy D Schmahmann; Satrajit S Ghosh
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

6.  Ataxic Symptoms in Huntington's Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone.

Authors:  Polina A Egorova; Aleksandra V Gavrilova; Ilya B Bezprozvanny
Journal:  Front Neurosci       Date:  2020-04-03       Impact factor: 4.677

7.  Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease.

Authors:  Florian Holtbernd; Chris C Tang; Andrew Feigin; Vijay Dhawan; Maria Felice Ghilardi; Jane S Paulsen; Mark Guttman; David Eidelberg
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

8.  Functional gradients of the cerebellum.

Authors:  Xavier Guell; Jeremy D Schmahmann; John DE Gabrieli; Satrajit S Ghosh
Journal:  Elife       Date:  2018-08-14       Impact factor: 8.140

9.  A mimetic peptide of α2,6-sialyllactose promotes neuritogenesis.

Authors:  Shuang-Xi Chen; Jia-Hui He; Yong-Jian Mi; Hui-Fan Shen; Melitta Schachner; Wei-Jiang Zhao
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

Review 10.  The Neurodevelopmental Hypothesis of Huntington's Disease.

Authors:  Ellen van der Plas; Jordan L Schultz; Peg C Nopoulos
Journal:  J Huntingtons Dis       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.